Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECTS
THE MEDICAL NEWS
Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment to counter the latest flare-up of the virus, health officials said on Tuesday, the first time it has been deployed against an active outbreak.... Advocacy groups on Tuesday filed a lawsuit challenging the decision by President Donald Trump's administration to allow Arkansas to impose work requirements on Medicaid recipients in the state.... Bayer AG unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts.... (Reuters Health) - People who have traumatic brain injuries may be nearly twice as likely to die by suicide as individuals who don't have a history of injuries like concussions and skull fractures, a large Danish study suggests.... (Reuters Health) - When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.... New York state on Tuesday sued Purdue Pharma LP, accusing the OxyContin maker of widespread fraud and deception in the marketing of opioids, and contributing to a nationwide epidemic that has killed thousands.... (Reuters Health) - After sex, men can sometimes experience a myriad of confusing negative feelings, a phenomenon called post-coital dysphoria (PCD), which can interfere with relationships, researchers say.... (Reuters Health) - Adults who sleep too little or too much may have an increased risk of heart attack or stroke, say researchers who argue that the best way to think of the harmful effect is in terms of "excess heart age."... (Reuters Health) - Tests for BRCA1 and BRCA2 - gene mutations that raise the risk of breast and ovarian cancers - are not always done in U.S. women who are eligible to get them, a new study suggests.... China's Ministry of Agriculture reported on Tuesday an outbreak of foot and mouth disease in its central province of Henan... Biogen's muscle disease treatment Spinraza has been deemed too expensive for use on Britain's state-run health service, even after a price discount offered by the U.S. drugmaker.... (Reuters Health) - The vapor from e-cigarettes may boost the production of inflammatory chemicals in the lungs, while disabling key cellular defenders against infection, a new study suggests.... (Reuters Health) - For decades, doctors have told parents to talk to kids as often as possible to help build speech and language skills. Now, a new study suggests that how parents talk to children may matter just as much as how much time they spend talking.... Many U.S. doctors don't discuss the harms of lung cancer screening or the potential for overdiagnosis in conversations with current and former smokers about whether tests are necessary, two new studies suggest.... (Reuters Health) - State laws designed to increase teen vaccination against the cancer-causing human papillomavirus (HPV) don't appear to influence adolescents' choices about whether to become sexually active or use condoms, a U.S. study suggests.... (Reuters Health) - When it comes to childhood obesity, sedentary behavior may be the most influential and controllable factor that parents can change, especially through managing screen time, according to a new American Heart Association Science Advisory.... Amicus Therapeutics on Monday set an average price of $315,000 per year for its newly approved Fabry disease treatment, a price it believes is below that of the main existing treatment in the United States.... Anglo-American biotech company Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million.... A Californian court finding that a Monsanto weedkiller caused cancer in a school groundskeeper sent shares in an Australian maker of a similar product, Nufarm Ltd, tumbling almost 17 percent to a more than two-year low on Monday.... A California jury on Friday found Monsanto liable in a lawsuit filed by a man who alleged the company's glyphosate-based weed-killers, including Roundup, caused his cancer and ordered the company to pay $289 million in damages....